We also elucidated the clinical significance of CXCL17 and GPR35, explored the potential pathways by which they participate in GC development thorough TCGA analysis, and analyzed their involvements in drug sensitivity by the Cancer Therapeutics Response Portal (CTRP) database. The gene discussed is GPR35; the disease is gastric cancer.